South America Travel Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines, and Others) and Application (Domestic Travel and Outbound Travel)

List of Tables

The travel vaccines market in SAM is expected to grow from US$ 143.20 million in 2021 to US$ 243.85 million by 2028; it is estimated to grow at a CAGR of 7.6% from 2021 to 2028.

The SAM travel vaccines market is segmented into Brazil, Argentina, and the Rest of SAM. During the forecast period, the region is expected to continue its dominance due to an increase in the prevalence of regional diseases, rapid technological innovations, vaccine development, and an increasing geriatric population. Brazil is the major vaccine manufacturer in the region. The country is self-sufficient for 54% of vaccination needs, including DTP, DT for adults and infants, TT, HepB, and DTP combined vaccines (DTP-HB and DTP-HB-Hib), seasonal influenza vaccine, YF vaccine, and meningo AþC. Brazil is one of the major worldwide producers of the YF vaccine, with the lowest market price. Similar to Brazil, Argentina is also the largest country in the region. Argentina has an upper middle-income economy with a diversified industrial sector. The country's GDP was US$ 123,369 million in 2021. The GDP of Argentina has grown at a compound rate of 6.8% over the last five years. Major countries contributing to the market's growth include Chile, Colombia, Peru, Cuba, Venezuela, and Bolivia. The countries offer significant growth opportunities for the growth of the market. The factors such as increasing focus on vaccine research, continuous advancements in vaccine development technologies, and increasing government spending on pharmaceutical R&D in the region are expected to boost the travel vaccines market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM travel vaccines market. The SAM travel vaccines market is expected to grow at a good CAGR during the forecast period.

SAM Travel Vaccines Market Revenue and Forecast to 2028 (US$ Million)

SAM Travel Vaccines Market Segmentation

SAM travel vaccines market is segmented into product, application, and country. The SAM travel vaccines market, based on product, is segmented into hepatitis A, hepatitis B, meningococcal vaccines, and others. In 2021, the others segment held the largest share of the market. The SAM travel vaccines market, based on application, is segmented into domestic travel and outbound travel. In 2021, the outbound travel segment held the largest share of the market. Based on country, the SAM travel vaccines market is segmented into Brazil, Argentina, and the Rest of SAM.

Abbott; GlaxoSmithKline plc; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; and Sanofi are among the leading companies in the travel vaccines market in the region.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the SAM travel vaccines market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the SAM travel vaccines market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the travel vaccines market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Product Code: BMIRE00025527

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 SAM Travel Vaccines Market - By Product
- 1.3.2 SAM Travel Vaccines Market - By Application
- 1.3.3 SAM Travel Vaccines Market - By Country

2. SAM Travel Vaccines Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. SAM Travel Vaccines Market- Market Landscape

4.1 Overview
4.2 SAM PEST Analysis
4.3 Expert Opinion

5. SAM Travel Vaccines Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Travel and Tourism is Growing
- 5.1.2 Growing Incidences of Infectious Diseases
5.2 Market Restraints
- 5.2.1 High Cost of Travel Vaccines
5.3 Market Opportunities
- 5.3.1 Awareness Regarding Vaccines
5.4 Future Trends
- 5.4.1 Continuous Ongoing Demand for Vaccines
5.5 Impact Analysis

6. Travel Vaccines Market - SAM Analysis

6.1 SAM Travel Vaccines Marker Revenue Forecast and Analysis

7. SAM Travel Vaccines Market Analysis - By Product

7.1 Overview
7.2 SAM Travel Vaccines Market Revenue Share, by Product (2021 and 2028)
7.3 Hepatitis A
- 7.3.1 Overview
- 7.3.2 Hepatitis A: Travel Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
7.4 Hepatitis B
- 7.4.1 Overview
- 7.4.2 Hepatitis B: Travel Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
7.5 Meningococcal Vaccines
- 7.5.1 Overview
- 7.5.2 Meningococcal Vaccines: Travel Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Travel Vaccines Market- Revenue and Forecast to 2028 (US$ Million)

8. SAM Travel Vaccines Market Analysis - By Application

8.1 Overview
8.2 SAM Travel Vaccines Market Revenue Share, by Application (2021 and 2028)
8.3 Domestic Travel
- 8.3.1 Overview
- 8.3.2 Domestic Travel: Travel Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
8.4 Outbound Travel
- 8.4.1 Overview
- 8.4.2 Outbound Travel: Travel Vaccines Market- Revenue and Forecast to 2028 (US$ Million)

9. SAM Travel Vaccines Market - Country Analysis

9.1 Overview
- 9.1.1 SAM: Travel Vaccines Market, by Country, 2020 & 2028 (%)
  - 9.1.1.1 Brazil: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.1.1 Brazil: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.1.2 Brazil: Travel Vaccines Market, by Product, 2019-2028 (US$ 'Million)
    - 9.1.1.1.3 Brazil: Travel Vaccines Market, by Application, 2019-2028 (US$ 'Million)
  - 9.1.1.2 Argentina: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.2.1 Argentina: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.2.2 Argentina: Travel Vaccines Market, by Product, 2019-2028 (US$ 'Million)
    - 9.1.1.2.3 Argentina: Travel Vaccines Market, by Application, 2019-2028 (US$ 'Million)
  - 9.1.1.3 Rest of SAM: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.3.1 Rest of SAM: Travel Vaccines Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 9.1.1.3.2 Rest of SAM: Travel Vaccines Market, by Product, 2019-2028 (US$ 'Million)
    - 9.1.1.3.3 Rest of SAM: Travel Vaccines Market, by Application, 2019-2028 (US$ 'Million)

10. Travel Vaccines Market-Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Travel Vaccines Market, (%)
10.3 Organic Developments
- 10.3.1 Overview
10.4 Inorganic Developments
- 10.4.1 Overview

11. Company Profiles

11.1 GlaxoSmithKline plc.
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Merck & Co., Inc.
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Sanofi
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Novartis AG
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Pfizer Inc.
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Abbott
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments

12. Appendix

12.1 About the Insight Partners
12.2 Glossary of Terms